✦ LIBER ✦

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges

✍ Scribed by Xiangdong Liu; Robert C. Newton; Peggy A. Scherle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress in cancer therapy targeting c-M

✍ Jung, Kyung Hee; Park, Byung Hee; Hong, Soon-Sun 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 560 KB

mTOR Signaling Pathway and mTOR Inhibito

✍ Alejandro Gomez-Pinillos; Anna C. Ferrari 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Challenges and successes in developing n

✍ De Francesco, Raffaele; Migliaccio, Giovanni 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 406 KB

Challenge and promise: roles for cluster

✍ Shannan, B; Seifert, M; Leskov, K; Willis, J; Boothman, D; Tilgen, W; Reichrath, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

Interferon-based therapy for dialysis pa

✍ CHEN-HUA LIU; CHUN-JEN LIU; JIA-HORNG KAO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

c-Met as a target for human cancer and c

✍ James G. Christensen; Jon Burrows; Ravi Salgia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 388 KB